Related references
Note: Only part of the references are listed.Safety Evaluation And Risk Assessment Ofd-Limonene
Young Woo Kim et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS (2013)
Erlotinib Preserves Renal Function and Prevents Salt Retention in Doxorubicin Treated Nephrotic Rats
Raed N. Bou Matar et al.
PLOS ONE (2013)
Chrysin suppresses renal carcinogenesis via amelioration of hyperproliferation, oxidative stress and inflammation: Plausible role of NF-κB
Muneeb U. Rehman et al.
TOXICOLOGY LETTERS (2013)
Alleviation of doxorubicin-induced nephrotoxicity and hepatotoxicity by chrysin in Wistar rats
Summya Rashid et al.
TOXICOLOGY MECHANISMS AND METHODS (2013)
Resveratrol attenuates doxorubicin-induced cellular damage by modulating nitric oxide and apoptosis
Gulperi Oktem et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2012)
The protective role of arjunolic acid against doxorubicin induced intracellular ROS dependent JNK-p38 and p53-mediated cardiac apoptosis
Jyotirmoy Ghosh et al.
BIOMATERIALS (2011)
Epicatechin attenuates doxorubicin-induced brain toxicity: Critical role of TNF-α, iNOS and NF-κB
Rasha H. Mohamed et al.
BRAIN RESEARCH BULLETIN (2011)
Rutin attenuates cisplatin induced renal inflammation and apoptosis by reducing NFκB, TNF-α and caspase-3 expression in wistar rats
Wani Arjumand et al.
FOOD AND CHEMICAL TOXICOLOGY (2011)
2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-α release: Implications for the reactive oxygen species-mediated mechanisms of chemobrain
Christopher D. Aluise et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Protective effect of Solanum torvum on doxorubicin-induced nephrotoxicity in rats
Mahalaxmi Mohan et al.
FOOD AND CHEMICAL TOXICOLOGY (2010)
Silymarin modulates doxorubicin-induced oxidative stress, Bcl-xL and p53 expression while preventing apoptotic and necrotic cell death in the liver
Nirav Patel et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2010)
Antioxidant potential of aroma compounds obtained by limonene biotransformation of orange essential oil
Mario R. Marostica Junior et al.
FOOD CHEMISTRY (2009)
Comparative analysis of essential oils from eight herbal medicines with pungent flavor and cool nature by GC-MS and chemometric resolution methods
Chenxi Zhao et al.
JOURNAL OF SEPARATION SCIENCE (2009)
Protective effect of Zingiber officinale roscoe against anticancer drug doxorubicin-induced acute nephrotoxicity
T. A. Ajith et al.
FOOD AND CHEMICAL TOXICOLOGY (2008)
Interleukin-10: new perspectives on an old cytokine
David M. Mosser et al.
IMMUNOLOGICAL REVIEWS (2008)
The immune system and cardiac repair
Nikolaos G. Frangogiannis
PHARMACOLOGICAL RESEARCH (2008)
Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium
Yuzhao Zhou et al.
TOXICOLOGICAL SCIENCES (2008)
Protection of doxorubicin-induced DNA damage by sodium selenite and selenomethionine in Wistar rats
Raquel Alves dos Santos et al.
NUTRITION RESEARCH (2007)
Collateral damage in cancer chemotherapy - Oxidative stress in nontargeted tissues
Yumin Chen et al.
MOLECULAR INTERVENTIONS (2007)
Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity
S Yilmaz et al.
TOXICOLOGY (2006)
Influence of a low-molecular-weight heparin derivative on the nitric oxide levels and apoptotic DNA damage in adriamycin-induced cardiac and renal toxicity
PR Deepa et al.
TOXICOLOGY (2006)
Differential induction and activation of NF-κB transcription complexes in radiation-induced chromosomally unstable cell lines
AR Snyder et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2005)
Ceramide reduction and transcriptional up-regulation of glucosylceramide synthase through doxorubicin-activated Sp1 in drug-resistant HL-60/ADR cells
Y Uchida et al.
CANCER RESEARCH (2004)
New embo member's review -: NF-κB and virus infection:: who controls whom
MG Santoro et al.
EMBO JOURNAL (2003)
Effects of erdosteine treatment against doxorubicin-induced toxicity through erythrocyte and plasma oxidant/antioxidant status in rats
E Fadillioglu et al.
PHARMACOLOGICAL RESEARCH (2003)
Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction
P Pacher et al.
CIRCULATION (2003)
Melatonin protects against myocardial doxorubicin toxicity in rats: role of physiological concentrations
E Sahna et al.
JOURNAL OF PINEAL RESEARCH (2003)
Increased plasma endothelin-1 and cardiac nitric oxide during doxorubicin-induced cardiomyopathy
MM Sayed-Ahmed et al.
PHARMACOLOGY & TOXICOLOGY (2001)
Doxorubicin and mechanical performance of cardiac trabeculae after acute and chronic treatment: a review
EL De Beer et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats
SY Saad et al.
PHARMACOLOGICAL RESEARCH (2001)
Basal and drug-induced antioxidant enzyme activities correlate with age-dependent doxorubicin oxidative toxicity
CA Pritsos et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2000)
Adriamycin-induced heart failure: mechanisms and modulation
P Singal et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2000)
β-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1β- and tumor necrosis factor-α (TNFα)-dependent, and involves a TNFα receptor-associated factor- and NFκB-inducing kinase-dependent signaling mechanism
KT Akama et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
